Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

GSK hit as darapladib flunks phase III test

Heart disease drug disappoints in late-stage trial

Deal Watch table for October 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during October 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

ProStrakan lines up new chairman for 2014

Dr John Brown will replace Peter Allen

- PMLiVE

Scotland first in UK to back Pfizer’s Inlyta

SMC also recommends Astellas' Xtandi but not Pfizer's Bosulif

National Institute for Health and Care Excellence NICE logo

NICE denies early use of Janssen’s Velcade

Draft guidance doesn't recommend expanded bone marrow cancer indication

- PMLiVE

Mobile health apps – still a novelty?

There are thousands of mobile health apps, but they've yet to live up to their potential

- PMLiVE

Roche names head of European comms

Promotes Susie Hackett

Celgene poaches Sanofi Pasteur’s medical director

Adrian Kilcoyne announced as David Gillen’s replacement

- PMLiVE

Boehringer to help promote genetic biomarker testing

Will support Bonnie J Addario Lung Cancer Foundation

China flag thumb

Diabetes management underestimated in Asia

Boehringer/Lilly survey highlights need to improve patient education in India, China, Japan and South Korea

- PMLiVE

AZ invests £120m in UK cancer drug production

New facility in Macclesfield to manufacture Zoladex will retain 300 jobs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links